The study conducted by Hadassah Medical Organization aims to elucidate the differences in the salivary microbiome between children with Type 1 Diabetes Mellitus (T1DM) and healthy controls. This research could have significant implications for understanding the oral health challenges faced by diabetic children, potentially leading to new diagnostic tools or therapeutic strategies. The market for diabetes management and related oral health products is substantial, with increasing awareness of the microbiome's role in health. Competitively, this study may position Hadassah as a leader in microbiome research related to diabetes, attracting partnerships or funding opportunities. Diligence implications include the need for further studies to validate findings and explore commercial applications.